Embed Size (px)
Citation preview
TABLE OF CONTENTS Volume 6, Number 6, November 2019 Neurology.org/NN
Editor’s Corner
e630 Learning from adverse treatment effectsJ. Dalmau
Open Access
Editorials
e617 Untangling normal aging from disease-related brainatrophy in MST. Sinnecker and J. Wuerfel
Open Access Companion article, p. e616
e629 Pembrolizumab as a treatment for PML? Waitingfor GodotR.A. Du Pasquier
Open Access Companion articles, p. e627 and e628
Articles
e604 Increased frequency of anti-Ma2 encephalitisassociated with immune checkpoint inhibitorsA. Vogrig, M. Fouret, B. Joubert, G. Picard, V. Rogemond, A.-L. Pinto,S. Muñiz‐Castrillo, M. Roger, J. Raimbourg, C. Dayen, L. Grignou,M. Pallix-Guyot, J. Lannoy, F. Ducray, V. Desestret, D. Psimaras, andJ. Honnorat
Open Access
e605 HLA and microtubule-associated protein tau H1haplotype associations in anti-IgLON5 diseaseC. Gaig, G. Ercilla, X. Daura, M. Ezquerra, R. Fernandez-Santiago,E. Palou, L. Sabater, R. Hoftberger, A. Heidbreder, B. Hogl, A. Iranzo,J. Santamaria, J. Dalmau, and F. Graus
Open Access
e607 Late-onset neuromyelitis optica spectrum disorder:The importance of autoantibody serostatusM. Sepulveda, G. Delgado-Garcıa, Y. Blanco, N. Sola-Valls,E.H. Martinez-Lapiscina, T. Armangue, C. Montejo,I. Pulido-Valdeolivas, E. Martinez-Hernandez, H. Ariño, D. Escudero,R. Ruiz-Garcıa, S. Llufriu, J. Dalmau, F. Graus, and A. Saiz
Open Access
e609 Glutamine antagonism attenuates physical andcognitive deficits in a model of MSK.R. Hollinger, M.D. Smith, L.A. Kirby, E. Prchalova, J. Alt, R. Rais,P.A. Calabresi, and B.S. Slusher
Open Access
e612 Neurochondrin neurological autoimmunityS. Shelly, T.J. Kryzer, L. Komorowski, R. Miske, M.D. Anderson,E.P. Flanagan, S.R. Hinson, V.A. Lennon, S.J. Pittock, and A. McKeon
Open Access
e614 Lymphocyte counts and infection rates: Long-termfingolimod treatment in primary progressive MSE.J. Fox, F.D. Lublin, J.S. Wolinsky, J.A. Cohen, I.M. Williams, X. Meng,M. Ziehn, S. Kolodny, and B.A.C. Cree
Open Access Class of Evidence
e615 Peripheral neuropathy in antineutrophil cytoplasmicantibody-associated vasculitides: Insights from theDCVAS studyA. Bischof, V.K. Jaeger, R.D.M. Hadden, R.A. Luqmani, A.-K. Probstel,P.A. Merkel, R. Suppiah, A. Craven, M.P. Collins, and T. Daikeler
Open Access
e616 Contribution of normal aging to brain atrophy in MSC.J.Azevedo,S.Y.Cen,A. Jaberzadeh,L. Zheng,S.L.Hauser,andD.Pelletier
Open Access Editorial, p. e617
e618 Progressive multifocal leukoencephalopathy:A 25-year retrospective cohort studyP. Anand, G.C. Hotan, A. Vogel, N. Venna, and F.J. Mateen
Open Access
e621 Effects of natalizumab therapy on intrathecal antiviralantibody responses in MSF. Largey, I. Jelcic, M. Sospedra, C. Heesen, R. Martin, and I. Jelcic
Open Access
e622 Vitamin D enhances responses to interferon-β in MSX. Feng, Z. Wang, Q. Howlett-Prieto, N. Einhorn, S. Causevic, andA.T. Reder
Open Access
e623 Elevated levels ofmiR-181c andmiR-633 in theCSF ofpatients with MS: A validation studyS. Kramer, A. Haghikia, C. Bang, K. Scherf, A. Pfanne, A. Duscha,J. Kaisler, B. Gisevius, R. Gold, T. Thum, and A. Haghikia
Open Access Class of Evidence
Cover ImageSimilar microbiome profiles in patients with anti-NMDAR encephalitisand control subjects. The figure shows multidimensional scaling plotsof Bray-Curtis distances at genera and Operational Taxonomic Unitslevel, demonstrating a high level of similarity regarding inter-individualdifferences between anti-NMDAR encephalitis patients and healthysubjects.See page e632
Continued
e625 Identification of circulating MOG-specific B cells inpatients with MOG antibodiesS. Winklmeier, M. Schluter, M. Spadaro, F.S. Thaler, A. Vural,R. Gerhards, C. Macrini, S. Mader, A. Kurne, B. Inan, R. Karabudak,F.G. Ozbay, G. Esendagli, R. Hohlfeld, T. Kumpfel, and E. Meinl
Open Access
e626 Classifying the antibody-negative NMO syndromes:Clinical, imaging, and metabolomic modelingT. Yeo, F. Probert,M. Jurynczyk,M. Sealey, A. Cavey, T.D.W. Claridge,M. Woodhall, P. Waters, M.I. Leite, D.C. Anthony, and J. Palace
Open Access
e631 IL6 receptor358Ala variant and trans-signaling aredisease modifiers in amyotrophic lateral sclerosisM. Wosiski-Kuhn, M. Robinson, J. Strupe, P. Arounleut, M. Martin,J. Caress, M. Cartwright, R. Bowser, M. Cudkowicz, C. Langefeld,G.A. Hawkins, and C. Milligan
Open Access
e632 Normal gut microbiome in NMDA receptorencephalitisJ. Herken, C. Bang, M.C. Ruhlemann, C. Finke, J. Klag, A. Franke, andH. Pruss
Open Access
Clinical/Scientific Notes
e606 Steroid-sparing agents for the treatment ofinflammation in complicated neurocysticercosisP. Anand, S.S. Mukerji, J. Thon, S. Gunaratne, T.A. Cho, and N. Venna
Open Access
e608 CNS-disseminated Angiostrongylus cantonensismimicking atypical demyelinating diseaseD. Long, K. Green, T. Derani, N. Decker, R.J. Pace, and R. Aburashed
Open Access
e611 Toll-like receptor 3 deficiency in autoimmuneencephalitis post–herpes simplex encephalitisT. Armangue, B.J. Baucells, A. Vlagea,M. Petit-Pedrol, A. Esteve-Sole,A. Deya-Martınez, R. Ruiz-Garcıa, M. Juan, R. Perez de Diego,J. Dalmau, and L. Alsina
Open Access
e613 CSF orexin-A levels after rituximab treatment inrecent onset narcolepsy type 1P. Wasling, C. Malmestrom, and K. Blennow
Open Access
e619 Expanding the MOG phenotype: Brainstemencephalitis with punctate and curvilinearenhancementS. Matesanz, C. Kotch, C. Perrone, A.J. Waanders, B. Hill, andS. Narula
Open Access
e620 Overnight loss of pigmented hair in autoimmuneautonomic neuropathy treated with IVIgL.E. Turner, S.J. Pittock, M.T. McEvoy, and E.P. Flanagan
Open Access
e624 Fatal PCR-negative herpes simplex virus-1encephalitis with GABAA receptor antibodiesS. Schuster, L. Abrante, J. Matschke, M. Lutgehetmann, B. Holst,M. Gelderblom, H. Braass, F. Leypoldt, and T. Magnus
Open Access
e627 Ineffective treatment of PML with pembrolizumab:Exhausted memory T-cell subsets as a clue?M. Pawlitzki, T. Schneider-Hohendorf, L. Rolfes, S.G. Meuth,H. Wiendl, N. Schwab, and O.M. Grauer
Open Access Editorial, p. e629
e628 Pembrolizumab for progressive multifocalleukoencephalopathy due to primaryimmunodeficiencyC. Kupper, J. Heinrich, K. Kamm, V. Bucklein, S. Rothenfusser, andA. Straube
Open Access Editorial, p. e629
Views & Reviews
e610 Generation of neuroinflammation in human AfricantrypanosomiasisJ. Rodgers, I. Steiner, and P.G.E. Kennedy
Open Access
TABLE OF CONTENTS Volume 6, Number 6, November 2019 Neurology.org/NN
Academy OfficersJames C. Stevens, MD, FAAN, PresidentOrly Avitzur, MD, MBA, FAAN, President ElectAnn H. Tilton, MD, FAAN, Vice PresidentCarlayne E. Jackson, MD, FAAN, SecretaryJanis M. Miyasaki, MD, MEd, FRCPC, FAAN, TreasurerRalph L. Sacco, MD, MS, FAAN, Past President
Executive Office, American Academy of NeurologyCatherine M. Rydell, CAEChief Executive Officer201 Chicago AveMinneapolis, MN 55415Tel: 612-928-6100
Editorial OfficePatricia K. Baskin, MS, Executive EditorKathleen M. Pieper, Senior Managing Editor, NeurologySharon L. Quimby, Managing Editor, Neurology® Clinical PracticeMorgan S. Sorenson, Managing Editor, Neurology® Neuroimmunology& Neuroinflammation
Lee Ann Kleffman, Managing Editor, Neurology® GeneticsAndrea Rahkola, Production Editor, NeurologyRobert J. Witherow, Senior Editorial AssociateKaren Skaja, Senior Editorial AssociateKaitlyn Aman Ramm, Editorial AssistantKristen Swendsrud, Editorial AssistantJustin Daugherty, Editorial AssistantMadeleine Sendek, MPH, Editorial Assistant
PublisherWolters KluwerBaltimore, MD
Publishing StaffKim Jansen, Executive PublisherJessica Heise, Production Team Leader, Neurology JournalsMegen Miller, Production EditorStacy Drossner, Production Associate
Neurology® is a registered trademark of the American Academy of Neurology(registration valid in the United States).
Neurology® Neuroimmunology & Neuroinflammation (eISSN 2332-7812) is anopen access journal published online for the American Academy of Neurology,201 Chicago Ave, Minneapolis, MN 55415, by Wolters Kluwer Health, Inc. at14700 Citicorp Drive, Bldg 3, Hagerstown, MD 21742. Business offices arelocated at Two Commerce Square, 2001 Market St., Philadelphia, PA 19103.Production offices are located at 351 West Camden Street, Baltimore, MD21201-2436. © 2019 American Academy of Neurology.
Neurology® Neuroimmunology & Neuroinflammation is an official journal of theAmerican Academy of Neurology. Journal website: Neurology.org/NN, AANwebsite: AAN.com
Copyright and Permission Information: Please go to the journal website(www.neurology.org/nn) and click the Permissions tab for the relevant article.Alternatively, send an email to [email protected]. Generalinformation about permissions can be found here: https://www.lww.com/journal-permission.
Disclaimer: Opinions expressed by the authors and advertisers are notnecessarily those of the American Academy of Neurology, its affiliates, or ofthe Publisher. The American Academy of Neurology, its affiliates, and thePublisher disclaim any liability to any party for the accuracy, completeness,efficacy, or availability of the material contained in this publication (includingdrug dosages) or for any damages arising out of the use or non-use of any of thematerial contained in this publication.
Advertising Sales Representatives: Wolters Kluwer, 333 Seventh Avenue, NewYork, NY 10001. Contacts: Eileen Henry, tel: 732-778-2261, fax: 973-215-2485,[email protected] and in Europe: Craig Silver, tel: +44 7855062 550 or e-mail: [email protected].
Careers & Events: Monique McLaughlin, Wolters Kluwer, Two CommerceSquare, 2001 Market Street, Philadelphia, PA 19103, tel: (215)-521- 8468, fax:215-521-8801; [email protected].
Reprints: Meredith Edelman, Commercial Reprint Sales, Wolters Kluwer,Two Commerce Square, 2001 Market Street, Philadelphia, PA 19103, tel:215-356-2721; [email protected]; [email protected].
Special projects: US & Canada: Alan Moore, Wolters Kluwer, Two CommerceSquare, 2001 Market Street, Philadelphia, PA 19103, tel: 215-521-8638,[email protected]. International: Andrew Wible, Senior Manager,Rights, Licensing, and Partnerships, Wolters Kluwer, [email protected].
Copyright © 2019 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.
A peer-reviewed clinical and translational neurology open access journal Neurology.org/NN
Neurology® Neuroimmunology & Neuroinflammation
EditorJosep O. Dalmau, MD, PhD
Deputy EditorScott S. Zamvil, MD, PhD, FAAN
Associate EditorsMarinos Dalakas, MD, FAANMichael Heneka, MDDennis Kolson, MD, PhDFriedmann Paul, MD
Editorial BoardRohit Aggarwal, MD, MSSergio E. Baranzini, PhDSusanne Benseler, MDJeffrey L. Bennett, MD, PhD, FAANSeverine Boillee, PhDMatthijs C. Brouwer, MD, PhDWolfgang Bruck, MDDavid B. Clifford, MD, FAANRussell C. Dale, MBChB, MRCP, PhDOscar H. Del Brutto, MD, FAANThomas G. Forsthuber, MDKazuo Fujihara, MDJeffrey M. Gelfand, MD, MAS, FAANJoseph El Khoury, MDMarkus P. Kummer, PhD
Jun Li, MD, PhDLin Mei, MD, PhDAndrew McKeon, MDChristopher Power, MDRichard M. Ransohoff, MDChristine Stadelmann, MDIsrael Steiner, MDLawrence Steinman, MDJesper Tegner, PhD, MScSilvia N. Tenembaum, MDMaarten J. Titulaer, MD, PhDAri Waisman, PhDHugh J. Willison, MBBS, PhDGregory F. Wu, MD, PhD
Neurology® Journals
Editor-in-ChiefRobert A. Gross, MD, PhD, FAAN
Deputy EditorBradford B. Worrall, MD, MSc, FAAN
Section Editors
BiostatisticsRichard J. Kryscio, PhDSue Leurgans, PhDV. Shane Pankratz, PhD
Classification of Evidence EvaluationsGary S. Gronseth, MD, FAAN
Equity, Diversity, and Inclusion (EDI)Roy H. Hamilton, MD, MS, FAANHolly E. Hinson, MD, MCR, FAAN
PodcastsStacey L. Clardy, MD, PhDJeffrey B. Ratliff, MD, Deputy Podcast Editor
OmbudsmanDavid S. Knopman, MD, FAAN
Scientific Integrity AdvisorRobert B. Daroff, MD, FAAN
Classification of Evidence Review TeamMelissa J. Armstrong, MDRichard L. Barbano, MD, PhD, FAANRichard M. Dubinsky, MD, MPH, FAANJeffrey J. Fletcher, MD, MScGary M. Franklin, MD, MPH, FAANDavid S. Gloss II, MD, MPH&TMJohn J. Halperin, MD, FAANJason Lazarou, MSc, MDSteven R. Messe, MD, FAANPushpa Narayanaswami, MBBS, DM, FAANAlex Rae-Grant, MD
Vision Neurology® Neuroimmunology &Neuroinflammation will be the premierpeer-reviewed journal in the fields ofneuroimmunology and neuroinflammation.
Mission Neurology: Neuroimmunology &Neuroinflammation will provide neurologistsand clinical research scientists withoutstanding peer-reviewed articles, editorials,and reviews to enhance patient care andfacilitate basic and translational research.
EditorialInquiries
Tel: 612-928-6400Toll-free: 800-957-3182 (US)Fax: [email protected]
StayConnected
facebook.com/NeurologyNN
twitter.com/greenjournal
youtube.com/user/NeurologyJournal
Copyright © 2019 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.
2019;6; Neurol Neuroimmunol Neuroinflamm 6 (6)
This information is current as of January 1, 2019
ServicesUpdated Information &
http://nn.neurology.org/content/6/6.full.htmlincluding high resolution figures, can be found at:
Supplementary Material http://nn.neurology.org/content/suppl/2019/11/08/6.6.DC1
Supplementary material can be found at:
Permissions & Licensing
http://nn.neurology.org/misc/about.xhtml#permissionsits entirety can be found online at:Information about reproducing this article in parts (figures,tables) or in
Reprints
http://nn.neurology.org/misc/addir.xhtml#reprintsusInformation about ordering reprints can be found online:
rights reserved. Online ISSN: 2332-7812.Published since April 2014, it is an open-access, online-only, continuous publication journal. Copyright . All
is an official journal of the American Academy of Neurology.Neurol Neuroimmunol Neuroinflamm
